On March 13, 2015, the Medicare Payment Advisory Commission (“MedPAC”) released its March 2015 “Report to the Congress, Medicare Payment Policy.” MedPAC is required by law to review on an annual basis Medicare payment policies and make recommendations
FDA Commissioner substantiates President’s request for more FSMA funding
Last week, Commissioner Margaret Hamburg defended the President’s FY 2016 budget request of $1.3 billion for the FDA— a $109.5 million increase to the food safety budget.
At the House Agriculture Appropriations Subcommittee hearing, Dr. Hamburg explained that
Pharma in Focus – reforming class actions for pharmaceutical claims
The issue of reforming class actions for pharmaceutical claims is highlighted in this opinion piece by Partner Toby Biddle on the Vioxx litigation.
This article was originally published by Pharma In Focus and is reproduced with permission.
Vioxx case highlights
FDA continues to take aim at misleading internet advertising
On February 26, 2015, the U.S. Food and Drug Administration (FDA) issued warning letters to nine manufacturers of products sold over the Internet, informing each that they improperly advertise their products with disease-related claims.
Focus on dietary supplements
Five of
Right to Appeal for Secondary Payer Determinations
Last week, CMS issued a final rule giving liability insurance, no-fault insurance, and workers’ compensation the right to appeal reimbursement demands from Medicare.
The final rule implements appeal rights created under the Strengthening Medicare and Repaying Taxpayers Act of